2-minute read
HDFN is a rare fetal syndrome that affects later pregnancies. Johnson & Johnson is pioneering research to help women at severe risk. Their clinical trial is currently enrolling women who are at risk for severe HDFN who have a history of severe HDFN in a prior pregnancy.
After a diagnosis of maternal fetal alloimmunization and losing baby Lucy to hemolytic disease of the fetus and newborn (HDFN), Bethany took action. She made it her mission to ensure that other mothers diagnosed with maternal alloimmunization had education about the risks of the disease and knew the steps for proper medical care and treatment so that their babies could survive HDFN.